Previous research showed that Treg cells could protect the CNS in the acute post-stroke phase by inhibiting inflammatory responses and reducing pro-inflammatory cytokines secretion, such as interleukin-17 (IL-17) and interferon-gamma (IFN-γ) (28–30). The gene discussed is IL17A; the disease is Stroke.